Published in TB and Outbreaks Week, March 11th, 2003
The researchers examined data on infections in hospitalized patients in 43 states and Washington, DC, from 1994 to 2000. Ailments included respiratory and urinary infections caused by a variety of bacteria.
Many germs had grown resistant to fluoroquinolones, a class of antibiotics that includes ciprofloxacin, known by the brand name Cipro.
In 1994, Cipro was effective against 86% of the bacteria samples analyzed, but that dropped to 76% by 2000, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.